| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |